Release of four registration technical review guidelines for aspartate aminotransferase test reagent

On October 29, the State Food and Drug Administration issued the notice on the issuance of four guiding principles of registration technical review, including aspartate aminotransferase test reagent, which indicated that in order to strengthen the supervision and guidance of the registration of medical devices and further improve the quality of registration review, the State Food and Drug Administration organized the formulation of aspartate aminotransferase test reagent note The guiding principles for technical review of registration, guiding principles for technical review of total cholesterol testing reagent registration, guiding principles for technical review of uric acid testing reagent registration and guiding principles for technical review of urea testing reagent registration are hereby promulgated For the specific content of penicillin, please refer to the attachment: guidelines for registration technology review of uric acid testing reagent Guidelines for registration technology review of docx aspartate aminotransferase testing reagent Guidelines for registration technology review of docx urea testing reagent Guidelines for registration technology review of DOC total cholesterol testing reagent